Are There Any Inhibitors of Beta Glucosidase and Their Toxicological Relevance?
Inhibitors of beta glucosidase, such as certain flavonoids and synthetic compounds, can modulate its activity. These inhibitors may have therapeutic applications, such as in the management of metabolic disorders like Gaucher's disease. However, they can also pose toxicological risks by altering the metabolism of endogenous and exogenous substances, potentially leading to adverse effects or drug interactions.
